Showing results (401-410 of 466) with videos related to

Sort By:
Pageof 47
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2026
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR databaseCorrado Campochiaro, Marie-Elise Truchetet, Madelon Vonk, et al.
Plos One|November 21, 2018
Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosisAnna-Maria Hoffmann-Vold, Stephen Samuel Weigt, Vyacheslav Palchevskiy, et al.
Rheumatology (Oxford, England)|March 26, 2021
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) databaseAntonietta Gigante, Anna-Maria Hoffmann-Vold, Danilo Alunni Fegatelli, et al.
NPJ Digital Medicine|September 1, 2025
Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR studyCécile Trottet, Manuel Schürch, Ahmed Allam, et al.
Rheumatology (Oxford, England)|September 13, 2022
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR databaseMichele Iudici, Denis Mongin, Elise Siegert, et al.
Chest|December 15, 2025
Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical PracticeAnthony J Esposito, Kavitha C Selvan, Carrie Richardson, et al.
Pageof 47